Chile’s National Advisory Committee on Immunization (CAVEI): Evidence-based recommendations for public policy decision-making on vaccines and immunization

Dabanch, Jeannette; González, Cecilia; Cerda, Jaime; Acevedo, Johanna; Calvo, Mario; Díaz, Eduardo; Endeiza, María L.; Inostroza, Jaime; Rodríguez, Jaime; Saldaña, Adiela; Santillana, Solange; Omeiri, Nathalie El; Bastías, Magdalena

doi:10.1016/j.vaccine.2019.06.069

Cited by 9 publications

(3 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Since 2016, the Global NITAG Network (GNN) has provided “a global platform to enable NITAGs to efficiently share and access knowledge, technical reviews, data, lessons learned, trends, and innovations” [ 137 , 138 ]. NITAG functionality, quality, and integration into the policy process have been evaluated to facilitate NITAG effectiveness and sustainability [ 138 , 139 ]. The WHO and the U.S. CDC have jointly developed competency-based trainings, relevant materials, and tools to fill identified capacity gaps.…”

Section: Discussionmentioning

confidence: 99%

National decision-making for the introduction of new vaccines: A systematic review, 2010–2020

Donadel

Panero

Ametewee

et al. 2021

Vaccine

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

National decision-making for the introduction of new vaccines: A systematic review, 2010–2020

Donadel

Panero

Ametewee

et al. 2021

Vaccine

View full text Add to dashboard Cite

“…Existing framework for collaboration [36]. Pragmatic collaboration: (1) Government, (2) Universities conducing trials, (3) Vaccination infrastructure, (4) Primary care vaccine administration (5) Electronic vaccine registry [37,38].…”

Section: Chilementioning

confidence: 99%

Integrated Management Systems (IMS) to Support and Sustain Quality One Health Services: International Lessons from the COVID-19 Pandemic by the IMIA Primary Care Working Group

et al. 2023

View full text Add to dashboard Cite

Objectives: One Health considers human, animal and environment health as a continuum. The COVID-19 pandemic started with the leap of a virus from animals to humans. Integrated management systems (IMS) should provide a coherent management framework, to meet reporting requirements and support care delivery. We report IMS deployment during, and retention post the COVID-19 pandemic, and exemplar One Health use cases. Methods: Six volunteer members of the International Medical Association’s (IMIA) Primary Care Working Group provided data about any IMS and One Health use to support the COVID-19 pandemic initiatives. We explored how IMS were: (1) Integrated with organisational strategy; (2) Utilised standardised processes, and (3) Met reporting requirements, including public health. Selected contributors provided Unified Modelling Language (UML) use case diagram for a One Health exemplar. Results: There was weak evidence of synergy between IMS and health system strategy to the COVID-19 pandemic. However, there were rapid pragmatic responses to COVID-19, not citing IMS. All health systems implemented IMS to link COVID test results, vaccine uptake and outcomes, particularly mortality and to provide patients access to test results and vaccination certification. Neither proportion of gross domestic product alone, nor vaccine uptake determined outcome. One Health exemplars demonstrated that animal, human and environmental specialists could collaborate. Conclusions: IMS use improved the pandemic response. However, IMS use was pragmatic rather than utilising an international standard, with some of their benefits lost post-pandemic. Health systems should incorporate IMS that enables One Health approaches as part of their post COVID-19 pandemic preparedness.

show abstract

“…En 2005 se incorpora la vacuna contra virus hepatitis B al PNI, para ir acorde a las metas de OMS respecto a disminuir el riesgo de infección crónica vacunando en forma temprana a los niños 35 . Por esto existe aún riesgo en población adulta con CH y TH que no fue vacunada según calendario del PNI.…”

Section: Hepatitis Bunclassified

Inmunizaciones en cirrosis y trasplante hepático: Puesta al día

Castro,

Endeiza

et al. 2023

Rev. méd. Chile

View full text Add to dashboard Cite

Vaccination for Cirrhosis and Liver Transplant PatientsPatients with cirrhosis and liver transplantation (LT) have a higher risk of infections, complications and death. Vaccines have historically been used to prevent and reduce the risk of complications from viral and bacterial infections. The population with cirrhosis and candidates for LT should be evaluated for immunity against the most relevant immuno-preventable infections, update corresponding immunizations according to the national vaccination program, and inoculate the missing vaccines based on these recommendations. In case of not reaching its inoculation prior to LT, in the post-LT period its vaccination status should be updated. All doctors involved in the health care of these patients must have knowledge about this important topic and be aware of the access and free availability for this population through the presentation of a special form incorporated into the National Immunization Program.

show abstract

Chile’s National Advisory Committee on Immunization (CAVEI): Evidence-based recommendations for public policy decision-making on vaccines and immunization

Cited by 9 publications

References 3 publications

National decision-making for the introduction of new vaccines: A systematic review, 2010–2020

National decision-making for the introduction of new vaccines: A systematic review, 2010–2020

Integrated Management Systems (IMS) to Support and Sustain Quality One Health Services: International Lessons from the COVID-19 Pandemic by the IMIA Primary Care Working Group

Inmunizaciones en cirrosis y trasplante hepático: Puesta al día

Contact Info

Product

Resources

About